The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 29, 2015
Filed:
Feb. 23, 2012
Applicants:
Syed F. A. Hossainy, Hayward, CA (US);
Paul M. Consigny, San Jose, CA (US);
Inventors:
Syed F. A. Hossainy, Hayward, CA (US);
Paul M. Consigny, San Jose, CA (US);
Assignee:
Abbott Cardiovascular Systems Inc., Santa Clara, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 38/28 (2006.01); A61F 2/82 (2013.01); A61K 31/436 (2006.01); A61K 31/426 (2006.01); A61K 31/4365 (2006.01); A61K 31/45 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/553 (2006.01); A61K 31/565 (2006.01); A61K 31/573 (2006.01); A61K 31/65 (2006.01); A61K 45/06 (2006.01); A61K 35/58 (2015.01); A61K 38/58 (2006.01);
U.S. Cl.
CPC ...
A61K 38/28 (2013.01); A61F 2/82 (2013.01); A61K 31/426 (2013.01); A61K 31/436 (2013.01); A61K 31/4365 (2013.01); A61K 31/45 (2013.01); A61K 31/4709 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/553 (2013.01); A61K 31/565 (2013.01); A61K 31/573 (2013.01); A61K 31/65 (2013.01); A61K 35/58 (2013.01); A61K 45/06 (2013.01); A61F 2250/0067 (2013.01); A61K 38/58 (2013.01);
Abstract
Embodiments of the present invention include methods for the treatment, prevention, or amelioration of vascular disease in diabetic patients. The methods include both implantation of a stent including a first drug. Some embodiments include additional therapy, such as the co-administration of another drug. Some embodiments involve different stent selection for a diabetic patient compared to a non-diabetic patient.